Harald Poth

Vorsitzender bei

Phenex Pharmaceuticals AG

Health Technology

Finance

Consumer Services

Profil

Harald Poth is currently the Chairman-Supervisory Board at Phenex Pharmaceuticals AG, Director at Acousia Therapeutics GmbH, and Senior Investment Manager at LBBW Venture Capital GmbH.
He holds a doctorate degree from the University of Hohenheim.

Aktive Positionen von Harald Poth

Unternehmen	Position	Beginn
LBBW Venture Capital GmbH LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million.	Private Equity Investor	-
Phenex Pharmaceuticals AG Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology	Vorsitzender	-
Acousia Therapeutics GmbH Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Harald Poth

Ausbildung von Harald Poth

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Harald Poth im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
LBBW Venture Capital GmbH LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million.	Finance
University of Hohenheim University of Hohenheim Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Phenex Pharmaceuticals AG Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology	Health Technology
Acousia Therapeutics GmbH Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application	Health Technology